PharmaResearch Co., Ltd. (214450.KQ)

KRW 259500.0

(2.77%)

Gross Profit Summary of PharmaResearch Co., Ltd.

PharmaResearch Co., Ltd.'s latest annual gross profit in 2023 was 182.25 Billion KRW , up 35.88% from previous year.
PharmaResearch Co., Ltd.'s latest quarterly gross profit in 2024 Q2 was 57.22 Billion KRW , up 19.24% from previous quarter.
PharmaResearch Co., Ltd. reported a annual gross profit of 134.12 Billion KRW in annual gross profit 2022, up 31.51% from previous year.
PharmaResearch Co., Ltd. reported a annual gross profit of 101.98 Billion KRW in annual gross profit 2021, up 51.09% from previous year.
PharmaResearch Co., Ltd. reported a quarterly gross profit of 49.67 Billion KRW for 2024 Q1, up 5.03% from previous quarter.
PharmaResearch Co., Ltd. reported a quarterly gross profit of 47.29 Billion KRW for 2023 Q4, down -2.66% from previous quarter.

Annual Gross Profit Chart of PharmaResearch Co., Ltd. (2023 - 2015)

Historical Annual Gross Profit of PharmaResearch Co., Ltd. (2023 - 2015)

Year	Gross Profit	Gross Profit Growth
2023	182.25 Billion KRW	35.88%
2022	134.12 Billion KRW	31.51%
2021	101.98 Billion KRW	51.09%
2020	67.5 Billion KRW	49.31%
2019	45.21 Billion KRW	33.13%
2018	33.96 Billion KRW	-4.25%
2017	35.46 Billion KRW	16.95%
2016	30.32 Billion KRW	19.82%
2015	25.31 Billion KRW	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	57.22 Billion KRW	19.24%
2024 Q1	49.67 Billion KRW	5.03%
2023 Q4	47.29 Billion KRW	-2.66%
2023 Q2	47.88 Billion KRW	24.43%
2023 Q1	38.48 Billion KRW	1.53%
2023 Q3	48.58 Billion KRW	1.47%
2023 FY	182.25 Billion KRW	35.88%
2022 Q1	30.3 Billion KRW	9.21%
2022 FY	134.12 Billion KRW	31.51%
2022 Q4	37.9 Billion KRW	18.71%
2022 Q2	33.99 Billion KRW	12.17%
2022 Q3	31.92 Billion KRW	-6.08%
2021 Q1	22.97 Billion KRW	5.31%
2021 Q2	25.74 Billion KRW	12.03%
2021 Q3	25.51 Billion KRW	-0.89%
2021 Q4	27.74 Billion KRW	8.75%
2021 FY	101.98 Billion KRW	51.09%
2020 Q2	17.86 Billion KRW	33.49%
2020 Q3	19.82 Billion KRW	10.97%
2020 Q4	21.82 Billion KRW	10.06%
2020 FY	67.5 Billion KRW	49.31%
2020 Q1	13.38 Billion KRW	-11.85%
2019 Q2	10.87 Billion KRW	-16.32%
2019 FY	45.21 Billion KRW	33.13%
2019 Q4	15.18 Billion KRW	37.47%
2019 Q3	11.04 Billion KRW	1.53%
2019 Q1	13 Billion KRW	38.97%
2018 FY	33.96 Billion KRW	-4.25%
2018 Q4	9.35 Billion KRW	2.37%
2018 Q3	9.13 Billion KRW	-9.76%
2018 Q1	9.59 Billion KRW	0.04%
2018 Q2	10.12 Billion KRW	5.51%
2017 Q3	9.59 Billion KRW	12.72%
2017 Q2	8.51 Billion KRW	1.86%
2017 Q1	8.35 Billion KRW	17.64%
2017 FY	35.46 Billion KRW	16.95%
2017 Q4	9.59 Billion KRW	-0.04%
2016 Q4	7.1 Billion KRW	-0.34%
2016 Q1	8.22 Billion KRW	14.69%
2016 FY	30.32 Billion KRW	19.82%
2016 Q3	7.12 Billion KRW	-14.84%
2016 Q2	8.37 Billion KRW	1.75%
2015 FY	25.31 Billion KRW	0.0%
2015 Q4	7.17 Billion KRW	2.01%
2015 Q3	7.03 Billion KRW	0.0%

Peer Gross Profit Comparison of PharmaResearch Co., Ltd.

Name	Gross Profit	Gross Profit Difference
HLB Co., Ltd.	-6.01 Billion KRW	3131.278%
iNtRON Biotechnology, Inc.	4.56 Billion KRW	-3896.056%
BINEX Co., Ltd.	56.65 Billion KRW	-221.691%
Bioneer Corporation	199.25 Billion KRW	8.531%
Anterogen.Co.,Ltd.	2.21 Billion KRW	-8134.014%
MEDIPOST Co., Ltd.	40.18 Billion KRW	-353.55%
CrystalGenomics, Inc.	1.45 Billion KRW	-12408.874%
Helixmith Co., Ltd	2.12 Billion KRW	-8489.432%
Chabiotech Co.,Ltd.	255.19 Billion KRW	28.581%
Medy-Tox Inc.	128.16 Billion KRW	-42.207%
Peptron, Inc.	1.14 Billion KRW	-15879.162%
Amicogen, Inc.	51.51 Billion KRW	-253.805%
Genexine, Inc.	387.48 Million KRW	-46935.383%
HLB Therapeutics Co.,Ltd.	6.69 Billion KRW	-2622.558%
LegoChem Biosciences, Inc.	17.79 Billion KRW	-924.059%
ALTEOGEN Inc.	31.19 Billion KRW	-484.178%
SillaJen, Inc.	1.45 Billion KRW	-12411.129%
JETEMA, Co., Ltd.	26.58 Billion KRW	-585.634%
OliX Pharmaceuticals,Inc	14.42 Billion KRW	-1163.701%
Genomictree Inc.	-1.03 Billion KRW	17648.247%
MedPacto, Inc.	-1.83 Billion KRW	10044.804%
D&D Pharmatech	18.67 Billion KRW	-875.824%
EASY BIO,Inc.	50.88 Billion KRW	-258.163%
GI Innovation, Inc.	1.98 Billion KRW	-9061.196%